The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution   Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)     Matthew Galsky Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; EMD Serono; Gilead Sciences; Janssen; Merck; Pfizer Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); Genentech/Roche (Inst); Janssen Oncology (Inst); Merck (Inst); Novartis (Inst) Patents, Royalties, Other Intellectual Property - METHODS AND COMPOSITIONS FOR TREATING CANCER AND RELATED METHODS. MOUNT SINAI SCHOOL OF MEDICINE July 2012 Application number: 20120322792   Gloria Hoi Ying Lin Employment - Pfizer Leadership - Pfizer Stock and Other Ownership Interests - Pfizer Patents, Royalties, Other Intellectual Property - Pfizer Travel, Accommodations, Expenses - Pfizer   Neal Shore Stock and Other Ownership Interests - Photocure Consulting or Advisory Role - Accord Research; Alessa Therapeutics; Amgen; Antev; Asieris Pharmaceuticals; Astellas Pharma; AstraZeneca; Aura Biosciences; Bayer; Bioprotect; Bristol-Myers Squibb/Sanofi; CG Oncology; Clarity Pharmaceuticals; Dendreon; Exact Imaging; Ferring; Fize Medical; Glytherix; ImmunityBio; InVitae; Janssen Scientific Affairs; Lantheus Medical Imaging; Lilly; MDxHealth; Medivation/Astellas; Merck; Minomic; Myriad Genetics; Novartis; Nusano; Pfizer; Photocure; PlatformQ Health; Promaxo; Protara Therapeutics; Sanofi; Siemens; Speciality Networks; Sumitomo Pharma Oncology; Telix Pharmaceuticals; Tolmar; Tutelix; Urogen pharma Research Funding - Abbvie; Advantagene; Amgen; Aragon Pharmaceuticals; Astellas Pharma; AstraZeneca; Bayer; Boston Scientific; Bristol-Myers Squibb/Pfizer; CG Oncology; Clovis Oncology; Dendreon; DisperSol; Endocyte; Exact Imaging; Exelixis; Ferring; FKD Therapies; FORMA Therapeutics; Foundation Medicine; Genentech; Guardant Health; InVitae; Istari Oncology; Janssen; Jiangsu Yahong Meditech; MDxHealth; Medivation; Merck; MT Group; Myovant Sciences; Myriad Genetics; Novartis; Nymox; OncoCellMDx; ORIC Pharmaceuticals; pacific edge; Palette Life Sciences; Pfizer; Plexxikon; POINT Biopharma; Propella Therapeutics; Propella Therapeutics; RhoVac; Sanofi; SeaGen; Sesen Bio; Steba Biotech; Theralase; Tolmar; Urogen pharma; Urotronic; US Biotest; Vaxiion; Veru; Zenflow   Gary Steinberg Stock and Other Ownership Interests - CG Oncology; enGene; ImmVira; Protara Therapeutics Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Aura Biosciences; Bristol-Myers Squibb; CG Oncology; enGene; Fidia Farmaceutici S. p. A.; ImmVira; Merck; Pfizer; Photocure; Protara Therapeutics; Tyra Biosciences; UroViu; Vesica Health Research Funding - Bristol-Myers Squibb; CG Oncology; enGene; Janssen; Merck; Pfizer/Seagen   Jens Bedke Consulting or Advisory Role - Apogepha; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Daiichi Sankyo Europe GmbH; Eisai; Ipsen; Janssen; Merck KGaA; MSD Oncology; Pfizer; Roche Speakers' Bureau - Apogepha; Astellas Pharma; Bristol-Myers Squibb; Ipsen; Merck KGaA; MSD Oncology; Pfizer Research Funding - Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); Ipsen (Inst); MSD Oncology (Inst); Pfizer (Inst); Roche (Inst); SeaGen (Inst) Travel, Accommodations, Expenses - Ipsen (Inst); Merck KGaA (Inst)   Joan Palou Consulting or Advisory Role - AstraZeneca; Fidia Pharma USA; Pfizer   Julia Brinkmann Employment - Pfizer Stock and Other Ownership Interests - Pfizer   Anna Maria Calella Employment - Pfizer Stock and Other Ownership Interests - Pfizer   Rossano Cesari Employment - Pfizer Stock and Other Ownership Interests - Pfizer Travel, Accommodations, Expenses - Pfizer   Craig Davis Employment - Pfizer   Sunhee Rosenthal Employment - Pfizer Stock and Other Ownership Interests - Pfizer   Wenjing Yang Employment - Pfizer Stock and Other Ownership Interests - Pfizer   Keith Ching Employment - Pfizer Stock and Other Ownership Interests - Pfizer Patents, Royalties, Other Intellectual Property - Pfizer   Michelle Saul Employment - Pfizer Stock and Other Ownership Interests - Pfizer   Suhas Vasant Vasaikar Employment - Pfizer Stock and Other Ownership Interests - Pfizer   Thomas Powles Honoraria - Astellas Pharma; AstraZeneca; BMS GmbH & Co. KG; Eisai; Exelixis; Incyte; Ipsen; Johnson & Johnson/Janssen; MashupMD; Merck; Merck Serono; Novartis; Pfizer; Roche; Seagen Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Eisai; Exelixis; Incyte; Ipsen; Johnson & Johnson; MashupMD; Merck; Merck Serono; MSD; Novartis; Pfizer; Roche; Seagen Research Funding - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Eisai; Exelixis; Ipsen; Johnson & Johnson; Merck Serono; MSD; Novartis; Pfizer; Roche; Seagen Travel, Accommodations, Expenses - AstraZeneca; Ipsen; MSD; Pfizer; Roche